Stay updated on Pembrolizumab Reirradiation in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision metadata updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. No visible changes to the study details.SummaryDifference0.0%

- Check54 days agoChange DetectedRevision: v3.4.2 is shown on the page header/footer. The prior government-funding operating-status notice has been removed, with no changes to the study details.SummaryDifference0.4%

- Check61 days agoChange DetectedA government funding notice is now displayed and the page shows an updated revision tag (v3.4.1) replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check68 days agoChange DetectedAdded a glossary toggle (Show glossary) and updated QC labels to 'Last Update Submitted that Met QC Criteria' with a new version tag 'Revision: v3.4.0', while removing the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and the previous revision entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Reirradiation in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Reirradiation in Glioblastoma Clinical Trial page.